Advances in clinical trials on perioperative immune checkpoint inhibitors for resectable non-small cell lung cancer: A comprehensive review-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Advances in clinical trials on perioperative immune checkpoint inhibitors for resectable non-small cell lung cancer: A comprehensive review

Published:2024-11 Issue: Volume:141 Page:112903
ISSN:1567-5769
Container-title:International Immunopharmacology
language:en
Short-container-title:International Immunopharmacology

Author:

Cui Siyuan,Wang Na,Liang Yangyueying,Meng Yuan,Shu Xinyi,Kong Fanming^ORCID

Publisher

Elsevier BV

Reference122 articles.

1. Cancer statistics, 2024;Siegel;CA Cancer J. Clin.,2024

2. The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer;Goldstraw;J. Thorac. Oncol.,2016

3. Preoperative evaluation of patients undergoing lung resection surgerya;Datta;Chest,2003

4. Preoperative chemotherapy for non-small-cell lung cancer: a systematic review and meta-analysis of individual participant data;NSCLC Meta-analysis Collaborative Group;The Lancet,2014

5. Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group;Pignon;J. Clin. Oncol.,2008

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP